GlassScriptPhysician profile
Andrew S Ryals
NPI 1508295601
$625.45
in general payments reported to CMS, 2019-2025
19 companies · $83.20 in 2025
The $83.20 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.23 · 2020: $23.62 · 2021: $42.98 · 2022: $49.66 · 2023: $182 · 2024: $160 · 2025: $83.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $132.82 | 2022-2023 | Mounjaro, Trulicity |
| Novo Nordisk INC | $67.29 | 2022-2025 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $65.90 | 2019-2021 | |
| Abbvie INC. | $53.35 | 2021-2024 | Vraylar |
| Sanofi-Aventis U.S. LLC | $41.78 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.38 | 2019 | |
| Amgen INC. | $31.26 | 2023-2024 | Repatha, Otezla |
| Dynavax Technologies Corporation | $27.79 | 2024-2025 | Heplisav-B |
| Organon LLC | $20.46 | 2024 | |
| Abbott Laboratories | $18.88 | 2025 | Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.48 | 2025 | Caplyta |
| Biohaven Pharmaceutical Holding Company LTD. | $18.00 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.62 | 2023 | Seglentis |
| Exact Sciences Corporation | $14.98 | 2024 | Cologuard Collection Kit |
| Pfizer INC. | $14.60 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $13.59 | 2024 | Givlaari |
| Glaxosmithkline, LLC. | $12.65 | 2019 | |
| Allergan, INC. | $12.40 | 2020 | |
| Esperion Therapeutics, INC. | $11.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Ryals listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.